The Safety of an Adenosine A1-Receptor Antagonist, Rolofylline, in Patients with Acute Heart Failure and Renal Impairment
Year: 2012
Type: article
Study design: Clinical Trial
Source: Drug Safety
Authors: John R. Teerlink, Vicente J. Iragui, Jay P. Mohr, Peter E. Carson, Paul J. Hauptman, David H. Lovett, Alan B. Miller, Ileana L. Piña, Scott Thomson, Paul D. Varosy, Michael R. Zile, John G.F. Cleland, Michael M. Givertz, Marco Metra, Piotr Ponikowski, Adriaan A. Voors, Beth A. Davison, Gad Cotter, Denise Wolko, Paul DeLucca, Christina M. Salerno, George A. Mansoor, Howard Dittrich, Christopher M. O’Connor, Barry M. Massie
Institutions: San Francisco VA Medical Center, University of California, San Francisco, University of California San Diego, Columbia University, Georgetown University, Saint Louis University, University of Florida Health Science Center, Case Western Reserve University, VA Eastern Colorado Health Care System, University of Colorado Denver, Medical University of South Carolina, University of Hull, Brigham and Women's Hospital, University of Brescia, Wroclaw Medical University, University Medical Center Groningen, Momentum Research, Merck & Co., Inc., Rahway, NJ, USA (United States), Duke Medical Center
Language: English
Subfield: Physiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2097253015